Wenyan Yu

1.0k total citations
59 papers, 723 citations indexed

About

Wenyan Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wenyan Yu has authored 59 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Wenyan Yu's work include RNA modifications and cancer (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Cancer-related molecular mechanisms research (5 papers). Wenyan Yu is often cited by papers focused on RNA modifications and cancer (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Cancer-related molecular mechanisms research (5 papers). Wenyan Yu collaborates with scholars based in China, United States and Australia. Wenyan Yu's co-authors include Nuo Duan, Shijia Wu, Zhouping Wang, Xianfeng Lin, Xiangyi Meng, Xiaowu Xu, Xianjun Yu, Yi Qin, Changxin Li and Chunrong Zhu and has published in prestigious journals such as Blood, Advanced Functional Materials and Analytical Chemistry.

In The Last Decade

Wenyan Yu

54 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenyan Yu China 15 357 134 100 92 83 59 723
Qingwu Tian China 16 400 1.1× 85 0.6× 84 0.8× 89 1.0× 46 0.6× 48 828
Zhen Qin China 17 437 1.2× 140 1.0× 89 0.9× 93 1.0× 61 0.7× 45 803
Peipei Cao China 18 458 1.3× 197 1.5× 97 1.0× 85 0.9× 44 0.5× 51 958
Pengcheng Liu China 12 357 1.0× 112 0.8× 100 1.0× 105 1.1× 52 0.6× 43 909
Davoud Jafari-Gharabaghlou Iran 17 355 1.0× 152 1.1× 56 0.6× 82 0.9× 59 0.7× 42 871
Yizhen Guo China 14 360 1.0× 158 1.2× 86 0.9× 94 1.0× 69 0.8× 29 704
Xiaolu Li China 20 673 1.9× 119 0.9× 58 0.6× 159 1.7× 60 0.7× 59 1.0k
Xianghong Wang China 15 505 1.4× 124 0.9× 95 0.9× 72 0.8× 39 0.5× 41 1.0k
Xueshibojie Liu China 18 412 1.2× 66 0.5× 133 1.3× 167 1.8× 92 1.1× 27 794

Countries citing papers authored by Wenyan Yu

Since Specialization
Citations

This map shows the geographic impact of Wenyan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyan Yu more than expected).

Fields of papers citing papers by Wenyan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyan Yu. The network helps show where Wenyan Yu may publish in the future.

Co-authorship network of co-authors of Wenyan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyan Yu. A scholar is included among the top collaborators of Wenyan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyan Yu. Wenyan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zhong, et al.. (2025). Long non-coding RNAs promote colorectal cancer development through other epigenetic modifications. Gastroenterology report. 13. goaf081–goaf081.
2.
Chen, Zhong, et al.. (2024). The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance. Cancer Control. 31. 2925692244–2925692244. 7 indexed citations
3.
Zhao, Yuzhen, Jian Jin, Fei Pei, et al.. (2024). Neutrophil hitchhiking nanoparticles enhance bacteria-mediated cancer therapy via NETosis reprogramming. Journal of Controlled Release. 367. 661–675. 12 indexed citations
4.
Yang, Xi, Wenyan Yu, Jiali Zhang, et al.. (2024). Discovery of aurovertin B as a potent metastasis inhibitor against triple-negative breast cancer: Elucidating the complex role of the ATF3-DUSP1 axis. Journal of Pharmacology and Experimental Therapeutics. 392(1). 100005–100005. 4 indexed citations
5.
Yu, Wenyan, et al.. (2024). Autophagy regulates apoptosis of colorectal cancer cells based on signaling pathways. Discover Oncology. 15(1). 367–367. 2 indexed citations
6.
Li, Nanxin, et al.. (2024). The mechanism and clinical application of farnesyl diphosphate farnesyltransferase 1 in cancer metabolism. Biochemical and Biophysical Research Communications. 719. 150046–150046.
7.
Chen, Yanhua, et al.. (2023). Are Librarians Ready for Space Transformation? A Systematic Review of Spatial Literacy for Librarians. Sustainability. 15(4). 3244–3244. 2 indexed citations
8.
Yu, Wenyan, Xianfeng Lin, Nuo Duan, Zhouping Wang, & Shijia Wu. (2023). A fluorescence and surface-enhanced Raman scattering dual-mode aptasensor for sensitive detection of deoxynivalenol based on gold nanoclusters and silver nanoparticles modified metal-polydopamine framework. Analytica Chimica Acta. 1244. 340846–340846. 50 indexed citations
9.
Yu, Wenyan, Xiaoyan Li, Hongbing Zhang, et al.. (2022). Transcription factor FoxM1 promotes cyst growth in PKD1 mutant ADPKD. Human Molecular Genetics. 32(7). 1114–1126. 6 indexed citations
10.
Yu, Wenyan, et al.. (2022). Knockdown of GSG2 Suppresses the Progression of Colorectal Cancer Cells. Genetic Testing and Molecular Biomarkers. 26(1). 26–36. 4 indexed citations
11.
Zhang, Weili, et al.. (2022). LINC00116 Is a Novel Prognostic Biomarker of Nonsmall Cell Lung Cancer. Genetic Testing and Molecular Biomarkers. 26(6). 340–347. 1 indexed citations
12.
Lin, Xianfeng, Changxin Li, Xiangyi Meng, et al.. (2022). CRISPR-Cas12a-mediated luminescence resonance energy transfer aptasensing platform for deoxynivalenol using gold nanoparticle-decorated Ti3C2Tx MXene as the enhanced quencher. Journal of Hazardous Materials. 433. 128750–128750. 92 indexed citations
13.
Duan, Nuo, Xianfeng Lin, Wenyan Yu, et al.. (2022). ZIF-8 base-aptamer “gate-lock” probes enable the visualization of a cascade response between deoxynivalenol and cytochrome c inside living cells. Microchimica Acta. 190(1). 39–39. 3 indexed citations
14.
Qin, Yi, et al.. (2021). Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis. Cell Proliferation. 55(1). e13167–e13167. 63 indexed citations
15.
Chen, Xin, Xue Sun, Xi Li, Lu Xu, & Wenyan Yu. (2021). LncRNA-HEIH is a Novel Diagnostic and Predictive Biomarker in Gastric Cancer. Genetic Testing and Molecular Biomarkers. 25(4). 284–292. 8 indexed citations
16.
Bai, Renren, Zhongxing Liang, Younghyoun Yoon, et al.. (2019). Development of CXCR4 modulators based on the lead compound RB-108. European Journal of Medicinal Chemistry. 173. 32–43. 10 indexed citations
17.
Wu, Rui, Wenyan Yu, Chuansheng Yao, et al.. (2019). Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis. European Journal of Medicinal Chemistry. 185. 111823–111823. 12 indexed citations
18.
Yu, Wenyan, Mei Geng, Jie Hao, et al.. (2017). Clinical Features and Prognosis Analysis of Hodgkin Lymphoma: A Multicenter Retrospective Study Over a Decade of Patients in China. Clinical Lymphoma Myeloma & Leukemia. 17(5). 274–282. 4 indexed citations
19.
Nie, Xin, et al.. (2014). Phosphorylation of PTEN increase in pathological right ventricular hypertrophy in rats with chronic hypoxia induced pulmonary hypertension. Chinese Medical Journal. 127(2). 338–342. 6 indexed citations
20.
Liu, Yuxin & Wenyan Yu. (2013). Heat shock-mediated regulation of IκB-α at the post-transcriptional level by HuR. Molecular Medicine Reports. 9(2). 553–559. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingwu Tian Breakdown of academic impact, for papers by Zhen Qin Breakdown of academic impact, for papers by Peipei Cao Breakdown of academic impact, for papers by Pengcheng Liu Breakdown of academic impact, for papers by Davoud Jafari-Gharabaghlou Breakdown of academic impact, for papers by Yizhen Guo Breakdown of academic impact, for papers by Xiaolu Li Breakdown of academic impact, for papers by Xianghong Wang Breakdown of academic impact, for papers by Xueshibojie Liu
Rankless by CCL
2026